“We believe that our recent FDA clearance for our H. pylori product coupled with the continued progress with our inFoods launch will further our commercial progress in driving meaningful revenue growth and achieving profitability,” said Zackary Irani, CEO of Biomerica. “We are looking forward to capitalize on our sales opportunities on multiple fronts while meeting our financial targets to grow the business and shareholder value.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BMRA: